Head-to-head · WeighScore
Beluga Health vs Ilant Health
The verdict
Ilant Health takes it — 56.8/100 to 55.8/100, but only just.
Ilant Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ilant Health is a value-based obesity and cardiometabolic care company distributed through employers and health plans rather than direct cash-pay. Beluga Health is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Beluga Health | Ilant Health |
|---|---|---|
| WeighScore | 55.8/100 | 56.8/100 |
| Grade | C | C |
| Scorecard rank | #430 | #407 |
| Semaglutide | Not disclosed | Not disclosed |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #430 · C
Strengths
- Supports GLP-1 care with compounded semaglutide and tirzepatide
- Board-certified providers and a 50-state medical infrastructure
- LegitScript certified with SOC 2 and ISO 27001 security
- Pharmacies follow FDA/USP standards with third-party batch testing
- Powers many DTC brands as a turnkey telehealth backbone
Where it loses points
- White-label B2B group, not a direct consumer-facing service
- Offers compounded, not FDA-approved branded, GLP-1s
- No public consumer pricing for the GLP-1 offering
- Cited among nationwide groups tied to FDA telehealth GLP-1 scrutiny
- Care quality varies by the consumer brand using the platform
Graded #407 · C
Strengths
- Value-based, outcomes-driven obesity care model
- Includes GLP-1 medications with transparent drug pricing for sponsors
- Care team of board-certified obesity providers and behavioral specialists
- Dietitians and peer navigators support adherence
- Data-driven stratification targets the right interventions
Where it loses points
- Distributed via employers and health plans, not direct cash-pay
- Individuals generally cannot enroll without sponsor coverage
- No public consumer pricing for GLP-1
- Access gated behind organizational buyers
- Not suited to consumers wanting direct-to-door GLP-1
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.